Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2003
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002103016A3 Human tachykinin-related splice variants and compositions thereof
09/04/2003WO2002093164A3 Pyridylpyrimidine derivatives as effective compounds against prion diseases
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS
09/04/2003WO2002049662A3 Use of the prion protein (prp) for suppression of bax-mediated apoptosis
09/04/2003WO2002049647A3 Novel therapeutic use of a thienylcyclohexylamine derivative
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003WO2002032932A3 Urotensin-ii agonists and antagonists
09/04/2003WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
09/04/2003WO2002002097A3 Methods for treating seizure disorders by inhibiting mapk pathway activation with nitriles
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London
09/04/2003US20030166989 Method of radiotherapy
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166935 Spiroazabicyclic heterocyclic compounds
09/04/2003US20030166928 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents
09/04/2003US20030166925 4-Substituted piperidine compound
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166721 Choline derivative for the treatment of alzheimer's disease
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166711 A non-peptide and a non- nucleotide compound, culture product of penicillium sp. SPF-3059
09/04/2003US20030166709 Use of an oily suspensions, containing the active ingredient in a solid phase a N-0923 (Rotigotine) for the treatment of diseases associated with dopamine metabolism, such as Parkinson's disease
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166703 Method of treatment
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166680 For treating serine protease or dual-serine protease mediated disorders
09/04/2003US20030166673 Medicines for the prevention and treatment of neurodegenerative diseases
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166668 Substituted heteroarylalkanoic acids
09/04/2003US20030166667 Potent ameliorating effect on dementia among the known BZ omega 3 receptor agonists and on learning and/or memory impairments induced by hypofunction of glutamatergic system or cholinergic system; Alzheimer's; cognition activators
09/04/2003US20030166665 4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders
09/04/2003US20030166664 E.g. 3-(1-(2-(5-(acetylamino)-2-methylphenyl)ethyl)piperidin--4-yl)-6-chloro-1H -indole; potent dopamine D4 ligands, dopamine antagonists; antiseratonin agents; psychoses; anxiolytic agents; antidepressants; side effects reduction
09/04/2003US20030166657 Treating an optically pure enantimer of zopiclone with 1-chloroethyl chloroformate or an azodicarboxylate followed hydrolysis; modulation of benzodiazepine receptors; sleep and behavioral disorders; anxiolytic agents
09/04/2003US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders
09/04/2003US20030166654 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
09/04/2003US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166639 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/04/2003US20030166638 Technical field
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166633 Pyridinylimidazoles
09/04/2003US20030166632 Method for treating a disease or condition responsive to opening of C1C-2 channel
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents
09/04/2003US20030166626 7-Hydroxyepiandrosterone having neuroprotective activity
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166582 Aryl fused azapolycyclic compounds
09/04/2003US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation
09/04/2003US20030166580 Substituted amino carboxamides for the treatment of alzheimer's disease
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166556 Immunoregulator
09/04/2003US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide
09/04/2003US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents.
09/04/2003US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes,
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166283 Drug screening a modulator as antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; genetic engineering, receptor binding assay, gene expression
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030166229 Human POSH-like protein 1
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant
09/04/2003US20030166044 Novel proteins
09/04/2003US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases
09/04/2003US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy
09/04/2003US20030166016 Assay methods for cyclin dependent kinases
09/04/2003US20030165958 Test and model for Alzheimer's disease
09/04/2003US20030165950 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in
09/04/2003US20030165907 Human glycine transporter type 2
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165818 Detecting modulators of serine protease/dipeptidyl peptidase activity for treating viral/muscular/bone/nervous system disorders
09/04/2003US20030165569 Composition for topical substance delivery
09/04/2003US20030165566 Sedative non-benzodiazepine formulations
09/04/2003US20030165507 Postexposure prophylaxis therapy
09/04/2003US20030165499 Compositions and methods for treating psoriasis
09/04/2003US20030165496 Alzheimer's disease
09/04/2003US20030165492 Administering Dna sequences; genetic engineering
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165485 Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 1833